Clinical Data on Tesofensine for Weight Loss Tesofensines weight loss potential was first demonstrated in a landmark 24-week randomized, double-blind, placebo-controlled trial published in The Lancet a study that quickly set it apart from other anti-obesity compounds
Published preclinical studies use it as a chemical research tool in cell and animal models investigating ERR signaling, mitochondrial function, cellular respiration, oxidative metabolism, and exercise-response pathways
Established in-office patients may take prescribed injections home as directed
"In range" means the blend matches a common standalone protocol
As a black, woman, and veteran-owned company, Defy is proud to partner with like-minded brands that are committed to empowering every single person to defy the odds and achieve their version of success, said CEO Megan Bushell